Hyderabad: Dr Reddy’s Laboratories Ltd. has been ranked among the top employers according to the 2024 Top Biotech and Pharma Employers Survey conducted by Science magazine.
This marks the third consecutive appearance of Dr. Reddy’s in the list.
In 2022, Dr. Reddy’s entered the prestigious list at rank 18 while in 2023, the company was placed at number 16 and in the latest 2024 rankings, Dr. Reddy’s is placed at number 15 with high scores in ’Employee Respect’, ‘Employee Loyalty’ and ‘Social Responsibility’.
The prestigious Science magazine is a U.S.-based peer-reviewed academic journal of the American Association for the Advancement of Science (AAAS) and one of the world’s top academic journals.
Since 2002, Science magazine has evaluated top organizations in biotech, pharma, and biopharma through its Top Employers Survey.
Commenting on the recognition, G.V. Prasad, Co-Chairman and Managing Director of Dr. Reddy’s said, “We stand for developing affordable and innovative pharmaceuticals by investing in cutting-edge science and technology, developing great scientists and creating an environment that nurtures innovation in all aspects of product development. Our colleagues have the freedom to pursue multiple career tracks within the organization and we expose them to the best ideas and knowledge in whatever field they choose to work in.”
“Our culture and identity have revolved around being bold, entrepreneurial, responsible, humble, empathetic. Our purpose of ‘Good Health Can’t Wait’ is a movement and call to action for all of us, and good health encompasses patients, people and planet. The opportunity is available to each colleague to do their life’s work at our company and make the world a better place. Our people are our pride, and nothing gives us more joy than to see our people realize their full potential in the company,” Prasad added.
A recent report by the Foundation for Advancing Science and Technology (FAST India) in collaboration with IIFL Securities on ‘State of Industry R&D in India’ ranked Dr. Reddy’s first
among Indian pharma companies in both R&D intensity and the proportion of PhD employees .
